Literature DB >> 11469429

Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope.

B Takase1, A Uehata, T Nishioka, K Isojima, K Satomura, F Ohsuzu, A Kurita.   

Abstract

INTRODUCTION: A reduction in left ventricular volume and an increase in epinephrine levels have been reported in tilt-induced neurally mediated syncope. To compare the mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt and to investigate the role of catecholamines, the temporal changes in plasma levels of norepinephrine and epinephrine and in left ventricular volume were measured. METHODS AND
RESULTS: The first study population consisted of 90 patients with syncope of unknown etiology and 12 control subjects. The second study population consisted of 43 patients with unexplained syncope. In the first study, head-up tilt (80 degree angle) was conducted for 40 minutes, and norepinephrine and epinephrine levels were measured. In the second study, all patients were randomly allocated to either isoproterenol test (20 patients) or nitroglycerin test (23 patients) for 20-minute head-up tilt. Isoproterenol infusion was given at a rate of 1 to 3 microg/min. Intravenous infusion of nitroglycerin was started at 250 microg/hour with increasing dosages up to 1,500 microg/hour. Norepinephrine and epinephrine were measured in peripheral venous blood. Left ventricular volumes were measured by echocardiography with patients in the supine position and during head-up tilt every 1 minute. End-diastolic volume and end-systolic volume were calculated. In the first study, 61 patients demonstrated a positive response and 29 patients demonstrated a negative response. Plasma norepinephrine changes during head-up tilt were not significantly different, whereas epinephrine levels were significantly higher in the positive patients than in the negative and control subjects (148 +/- 118 pg/mL vs 66 +/- 31 pg/mL and 55 +/- 27 pg/mL). Thirteen of the 20 patients given isoproterenol and 15 of the 23 patients given nitroglycerin showed a positive head-up tilt (65.0% vs 65.2%; P = NS). During isoproterenol and nitroglycerin infusion head-up tilt, epinephrine in the positive group determined by the nitroglycerin test was significantly higher than that in the other three groups (103 +/- 38 pg/mL vs 60 +/- 33 pg/mL, 31 +/- 21 pg/mL, and 50 +/- 52 pg/mL). In contrast, end-systolic volume was significantly smaller in the positive group than in the other three groups based on findings of the isoproterenol test.
CONCLUSION: The findings suggest that nitroglycerin triggers head-up tilt-induced syncope by increasing epinephrine levels, whereas isoproterenol induces syncope by decreasing left ventricular volume.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469429     DOI: 10.1046/j.1540-8167.2001.00791.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  Clinical predictors of head-up tilt test outcome during the nitroglycerin phase.

Authors:  Massimo Iacoviello; Cinzia Forleo; Pietro Guida; Marco Matteo Ciccone; Sandro Sorrentino; Valentina D'Andria; Mariligia Panunzio; Stefano Favale
Journal:  Clin Auton Res       Date:  2009-06-30       Impact factor: 4.435

Review 2.  Sympathoneural and adrenomedullary responses to mental stress.

Authors:  Jason R Carter; David S Goldstein
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

3.  Neurally mediated syncope after thoracic surgery diagnosed in the intensive care unit.

Authors:  Noriyuki Matsutani; Bonpei Takase; Yuichi Ozeki; Masayuki Ishihara; Tadaaki Maehara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-11

4.  Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients.

Authors:  Lingping Xu; Xiangqi Cao; Rui Wang; Yichao Duan; Ye Yang; Junlong Hou; Jing Wang; Bin Chen; Xianjun Xue; Bo Zhang; Hua Ma; Chaofeng Sun; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.